KCC2/SLC12A5 Antibody (905705) [Janelia Fluor® 635]
Novus Biologicals, part of Bio-Techne | Catalog # FAB8369JF635
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry, Western Blot
Label
Janelia Fluor 635
Antibody Source
Monoclonal Mouse IgG1 Clone # 905705
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
NS0 mouse myeloma cell line transfected with human SLC12A5
Accession # Q9H2X9
Accession # Q9H2X9
Specificity
Detects human SLC12A5 in ELISAs and Western blots.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for KCC2/SLC12A5 Antibody (905705) [Janelia Fluor® 635]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
0
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: KCC2/SLC12A5
Long Name
K-Cl Cotransporter 2
Alternate Names
SLC12A5
Gene Symbol
SLC12A5
Additional KCC2/SLC12A5 Products
Product Documents for KCC2/SLC12A5 Antibody (905705) [Janelia Fluor® 635]
Product Specific Notices for KCC2/SLC12A5 Antibody (905705) [Janelia Fluor® 635]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...